WHO mapping out COVID-19 vaccines
WHO is creating a roadmap to develop COVID-19 vaccines
Scientists from biopharma companies, universities and regulatory agencies met at the WHO Feb. 11-12 to draw a roadmap for the development of vaccines to protect against COVID-19 amid a rapidly shifting terrain.
While knowledge about the disease is limited and changing daily, vaccine development is moving at an unprecedented pace. Priorities out of the WHO meeting include drafting a target product profile (TPP), designing a master protocol to test multiple vaccine candidates in parallel, and coordinating international work on animal models and standards, scientists who attended the meeting told BioCentury (see "Designing a Master Protocol for 2019-nCoV Outbreak").
The meeting, which considered a range of R&D issues in addition to vaccine development, was co-sponsored by WHO and the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). The vaccine working group was chaired by Philip Krause, deputy director of the Office of Vaccines Research and Review at FDA’s Center for Drug Evaluation